Targeting LAG-3 Across Tumor Types: Clinical Insights on New Data
Recorded Courses
hosted byProjects In Knowledge Inc. (PIK)
hosted byProjects In Knowledge Inc. (PIK)
attend it anywhere online
category
Pharmacy, Nursing, Medicine, Healthcare Management
Oncology
price
Free
Targeting LAG-3 Across Tumor Types: Clinical Insights on New Data is organized by Projects In Knowledge Inc. (PIK).
Release Date: Apr 10, 2023
Termination Date: Apr 09, 2024
Activity Goal:
The goal of this program is to provide clinicians with a resource to help them understand the key principles of immune checkpoint targets to improve and optimize patient outcomes.
Learning Objective(s):
• Evaluate recent clinical data for new and emerging checkpoint-targeting therapeutic approaches.
• Consider appropriate checkpoint-targeting therapeutic regimens for cancer treatment across tumor types.
Additional details will be posted as soon as information is available.